Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-03-28
1991-11-05
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548365, A61K 31415, C07D23122
Patent
active
050632450
ABSTRACT:
The present invention relates to a method of producing corticotropin-releasing factor (CRF) antagonist activity and thus provides a method of treating a wide range of stress-related disorders, including affective illnesses, such as depression and anxiety, as well as irritable bowel syndrome, anorexia nervosa, cardiovascular abnormalities and stress-induced immune suppression. The invention also relates to compounds (4-substituted thio-5-oxo-3-pyrazolines) and to pharmaceutical compositions suitable for use in such a method.
Abreu Mary E.
Elliott Richard L.
Hiner Roger N.
Kyle Donald J.
Rzeszotarski Waclaw
Fabiano Vincent L.
Nova Pharmaceutical Corporation
Ramsuer Robert W.
LandOfFree
Corticotropin-releasing factor antagonism compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Corticotropin-releasing factor antagonism compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Corticotropin-releasing factor antagonism compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-499648